|
시장보고서
상품코드
2051285
항진균제 시장 : 약제 유형별, 적응증별, 제형별, 유통 채널별, 지역별Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography |
||||||
항진균제 시장은 2026년에 155억 5,000만 달러에 달하고, 2033년까지 200억 6,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 3.7%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 155억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 3.70% | 시장 규모 예측(2033년) : | 200억 6,000만 달러 |
항진균제는 개인의 진균 감염 치료에 사용됩니다. 손발톱 백선이나 백선과 같은 일반적인 진균 감염증은 보통 신체 표면에서 발생하지만, 특정 침습성 진균 감염증은 신체 조직 내부나 폐, 뇌와 같은 내장 기관 내부에서 발생합니다. 진균 감염은 일반적으로 HIV/AIDS 환자 등 면역력이 저하된 사람들과 관련이 있습니다. 또한, 화학요법을 받고 있는 환자는 침습성 진균 감염에 걸리기 쉬운 경향이 있습니다. 항진균제는 진균 세포를 사멸시키거나 그 증식을 억제함으로써 진균 감염에 대항합니다. 항진균제는 크게 외용 항진균제, 경구 항진균제, 정맥 내 투여 항진균제, 그리고 질 내 투여용 항진균 페서리로 분류됩니다.
시장 역학
시장의 주요 기업들은 시장 내 입지를 강화하기 위해 제휴 및 계약과 같은 성장 전략에 주력하고 있습니다. 예를 들어, 2017년 6월, 바이오의약품 기업인 바실레아 파마슈티카(Basilea Pharmaceuticals)는 자사의 항진균 치료제 판매권과 관련하여 화이자(Pfizer) 및 아비아 파마(Avia Pharma)와 계약을 체결했습니다. 화이자는 러시아, 이스라엘, 유럽(북유럽 국가 제외), 튀르키예 등의 지역에서 생명을 위협하는 침습성 진균 감염증 치료제를 제조 및 판매합니다.
마찬가지로, 시장의 주요 기업들은 제품 포트폴리오를 확대하기 위해 연구개발 등 다양한 사업 전략에 주력하고 있습니다. 의약품 개발 증가가 이 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2019년 1월, 생명공학 기업인 SCYNEXIS, Inc.는 진행 중인 FURI 임상시험의 첫 중간 유효성 분석 결과가 양호하다고 발표했습니다. 이 새로운 치료법의 개발은 항진균 치료를 목적으로 하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 항진균제 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 항진균제 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진출기업 및 금융 애널리스트를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 항진균제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 항진균제 시장 : 약제 유형별(2021-2033년)
제5장 세계의 항진균제 시장 : 적응증별(2021-2033년)
제6장 세계의 항진균제 시장 : 제형별(2021-2033년)
제7장 세계의 항진균제 시장 : 유통 채널별(2021-2033년)
제8장 세계의 항진균제 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KTH 26.06.17Anti Fungal Drugs Market is estimated to be valued at USD 15.55 Bn in 2026 and is expected to reach USD 20.06 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 15.55 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.70% | 2033 Value Projection: | USD 20.06 Bn |
Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.
Market Dynamics
Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.
Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
- It profiles leading players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
- Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
- The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market.
Market Segmentation
- By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
- By Application (Revenue, USD Bn, 2021 - 2033)
- Neurosurgery
- Plastic Surgery
- Cardiovascular Surgery
- Obstetrics & Gynecology
- Others
- By Indication (Revenue, USD Bn, 2021 - 2033)
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Mucormycosis
- Others
- By Dosage Form (Revenue, USD Bn, 2021 - 2033)
- Powders
- Ointments
- Injections
- Tablets
- Others
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GlaxoSmithKline Plc
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc.
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc.
- Pfizer Inc.
- Gilead Sciences, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Anti Fungal Drugs Market, By Drug Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Allylamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
5. Global Anti Fungal Drugs Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Aspergillosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Dermatophytosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Mucormycosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
6. Global Anti Fungal Drugs Market, By Dosage Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Anti Fungal Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Anti Fungal Drugs Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2021 - 2033, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- GlaxoSmithKline Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Glenmark Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Enzon Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Gilead Sciences, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Astellas Pharma, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Alembic Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- SCYNEXIS, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GlaxoSmithKline Plc
10. Section
- References
- Research Methodology
- About us and Sales Contact
